Cite
MLA Citation
Kara M. Ruicci et al.. “A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth.” International journal of cancer, vol. 145, no. 8, 2019, pp. 2100–2106. http://access.bl.uk/ark:/81055/vdc_100089694619.0x00005e